US federal authorities have arrested a senior official of Canadian healthcare company CANARX over allegations of operating a long-running scheme to illegally import prescription medicines into the United States.
John Thomas Howard, the company's treasurer and a director, was arrested on Sunday. He faces charges including smuggling, conspiracy, illegal drug importation and introducing misbranded drugs into interstate commerce, according to federal court records.
His brother, Bob Howard, who serves as CANARX's president and a director, is also wanted in connection with the investigation but has not been arrested.
Investigation Covers Nearly a Decade
An affidavit filed by a special agent with the US Food and Drug Administration's Office of Criminal Investigations alleges that CANARX illegally imported or arranged the importation of prescription medicines into the country.
The criminal complaint covers alleged activities between February 2017 and April 2026. Investigators have not publicly specified all the medicines involved in the case.
CANARX, headquartered in Windsor, Ontario, provides prescription medication through programmes that source drugs from countries including Canada, the United Kingdom, Australia and New Zealand.
Company Denies the Allegations
The company's general counsel, Joseph Morris, told CNBC that the Howard brothers deny all charges and intend to defend themselves vigorously. He said they expect to be vindicated in court.
CANARX has previously faced regulatory scrutiny. In 2019, the FDA issued a warning letter concerning its drug-importation practices. In 2023, the agency also seized a shipment of medication linked to the company over concerns that the products could be misbranded or counterfeit.
Broader Scrutiny of Drug Importation
The case has drawn attention to alternative funding programmes, which help employers and health plans reduce prescription costs by sourcing medicines internationally.
Although US regulations permit personal drug imports in limited circumstances, the FDA says importing foreign prescription medicines as substitutes for approved domestic products is generally not permitted.
Separately, pharmaceutical company Gilead Sciences has filed a civil lawsuit accusing CANARX and other companies of illegally importing its HIV treatment Biktarvy. The allegations in the criminal case have not yet been established in court.
News Highlights:-